NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 934.50
-4.80 (-0.51%)
Jun 3, 2026, 3:30 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 168.24 billion as of June 3, 2026. Its market cap has increased by 13.84% in one year.
Market Cap
168.24B
Enterprise Value
154.09B
Revenue
40.78B
Ranking
n/a
PE Ratio
11.86
Stock Price
934.50
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 168.24B, an increase of 39,080.81%. That is a compound annual growth rate of 24.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 168.24B | 4.01% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 366.05B |
| Wockhardt | 349.83B |
| Emcure Pharmaceuticals | 323.29B |
| Piramal Pharma | 226.93B |
| Eris Lifesciences | 191.00B |
| Cohance Lifesciences | 164.27B |
| Alembic Pharmaceuticals | 141.53B |
| Alivus Life Sciences | 128.63B |